C-reactive protein is associated with aortic stiffness in a cohort of African American and white women transitioning through menopause

Menopause

Volumn 18, Issue 12, 2011, Pages 1291-1297

  Woodard, Genevieve A ^a   Mehta, Vinay G ^b   MacKey, Rachel H ^a   Tepper, Ping ^a   Kelsey, Sheryl F ^a   Newman, Anne B ^a   Sutton Tyrrell, Kim ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

African American; Arterial stiffness; C reactive protein; Cardiovascular disease; Menopause

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AFRICAN AMERICAN; AGE; ARTERIAL STIFFNESS; CARDIOVASCULAR RISK; CLIMACTERIUM; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; HUMAN; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PULSE WAVE; RACE;

AFRICAN AMERICANS; AORTA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ELASTICITY IMAGING TECHNIQUES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIMENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; ULTRASONOGRAPHY, DOPPLER;

EID: 83055188154     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31821f81c2     Document Type: Conference Paper

References (63)

1. Lakatta EG, Mitchell JH, Pomerance A, Rowe GG. Human aging: changes in structure and function. J Am Coll Cardiol 1987;10:42A-47A. (Pubitemid 17124576)
2. O'Rourke M. Mechanical principles in arterial disease. Hypertension 1995;26:2-9.
3. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994;140:669-682. (Pubitemid 24322180)
4. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-490.
5. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-1241. (Pubitemid 34163575)
6. Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001;12:2117-2124. (Pubitemid 32880348)
7. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998;32:570-574. (Pubitemid 28429151)
8. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003;63:1852-1860. (Pubitemid 36513333)
9. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005;111:3384-3390. (Pubitemid 40923391)
10. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874. (Pubitemid 36019640)
11. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138:419-420.
12. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
13. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003;21:315-325.
14. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl JMed 2002;347: 1557-1565. (Pubitemid 35315836)
15. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
16. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-2011. (Pubitemid 28243661)
17. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428. (Pubitemid 28090212)
18. Ridker PM. Intercellular adhesion molecule (ICAM-1) and the risks of developing atherosclerotic disease. Eur Heart J 1998;19:1119-1121. (Pubitemid 28362593)
19. Writing Committee Members, Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010;122:2748-2764.
20. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002;89:12E-17E.
21. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90-119. (Pubitemid 34185307)
22. Jonason T, Henriksen E, Kangro T, Vessby B, Ringqvist I. Menopause is associated with the stiffness of the common carotid artery in 50-year-old women. Clin Physiol 1998;18:149-155.
23. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811. (Pubitemid 29266405)
24. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008;15: 414-421. (Pubitemid 351656744)
25. Woodard GA, Brooks MM, Barinas-Mitchell E, Mackey RH, Matthews KA, Sutton-Tyrrell K. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 2011;18:376-384.
26. Kusche-Vihrog K, Urbanova K, Blanque A, et al. C-reactive protein makes human endothelium stiff and tight. Hypertension 2011;57:231-237.
27. Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 2009;206:61-68.
28. Arroyo-Espliguero R, Mollichelli N, Avanzas P, et al. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J 2003;24:2006-2011. (Pubitemid 37420447)
29. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004;24: 969-974. (Pubitemid 38620880)
30. Mattace-Raso FU, van der Cammen TJ, van der Meer IM, et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 2004;176:111-116. (Pubitemid 39078652)
31. Nagano M, Nakamura M, Sato K, Tanaka F, Segawa T, Hiramori K. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 2005;180:189-195.
32. Tomiyama H, Arai T, Koji Y, et al. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men. Atherosclerosis 2004;174:373-377. (Pubitemid 38597096)
33. Tomiyama H, Koji Y, Yambe M, et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005;45:997-1003. (Pubitemid 40628950)
34. Xu L, Jiang CQ, Lam TH, et al. Brachial-ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-CVD. Diabetes Metab Res Rev 2010;26:133-139.
35. Lieb W, Larson MG, Benjamin EJ, et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 2009;119:37-43.
36. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46:1118-1122. (Pubitemid 41533013)
37. Maggio M, Ceda GP, Lauretani F, et al. SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab 2011; 96:1053-1059.
38. Crandall C, Palla S, Reboussin B, et al. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. J Womens Health (Larchmt) 2006;15:14-23. (Pubitemid 43192858)
39. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008;54:1027-1037. (Pubitemid 351793410)
40. Sutton-Tyrrell K, Mackey RH, Holubkov R, Vaitkevicius PV, Spurgeon HA, Lakatta EG. Measurement variation of aortic pulse wave velocity in the elderly. Am J Hypertens 2001;14:463-468. (Pubitemid 32417603)
41. Farhat GN, Cauley JA, Matthews KA, et al. Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res 2006;21:1839-1846. (Pubitemid 44851559)
42. Myers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease ControlYNational Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 1989;9:105-135. (Pubitemid 19070302)
43. Warnick GR, Albers JJ. A comprehensive evaluation of the heparinmanganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978;19:65-76. (Pubitemid 8268303)
44. Stein EA, Steiner PM, Gartside PS, Glueck CJ. Development and evaluation of a method for quantitation of plasma high-density-lipoprotein cholesterol. Clin Chem 1978;24:1112-1115. (Pubitemid 8372761)
45. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
46. Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol 2009;103:1411-1416.
47. Saijo Y, Utsugi M, Yoshioka E, et al. Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population. Environ Health Prev Med 2009;14: 159-164.
48. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004;93:1238-1242. (Pubitemid 38595677)
49. Lakoski SG, Herrington DM, Siscovick DM, Hulley SB. C-reactive protein concentration and incident hypertension in young adults: the CARDIA study. Arch Intern Med 2006;166:345-349. (Pubitemid 43244323)
50. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290:2945-2951. (Pubitemid 37505526)
51. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 2006;20:498-504. (Pubitemid 44175794)
52. Patel DA, Srinivasan SR, Xu JH, Li S, Chen W, Berenson GS. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism 2006;55:699-705.
53. Carroll JF, Fulda KG, Chiapa AL, et al. Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring) 2009;17:1420-1427.
54. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46:464-469. (Pubitemid 41040287)
55. Lewis TT, Aiello AE, Leurgans S, Kelly J, Barnes LL. Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun 2010; 24:438-443.
56. Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem 2009;55:1627-1636.
57. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003;41:183-187. (Pubitemid 36056812)
58. Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 2007;49:981-985. (Pubitemid 351664328)
59. Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol 2004;93:221-225. (Pubitemid 38058737)
60. Tanaka H, DeSouza CA, Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998;18:127-132. (Pubitemid 28047609)
61. Boreham CA, Ferreira I, Twisk JW, Gallagher AM, Savage MJ, Murray LJ. Cardiorespiratory fitness, physical activity, and arterial stiffness: the Northern Ireland Young Hearts Project. Hypertension 2004;44: 721-726. (Pubitemid 39435244)
62. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 2003;1:65-78.
63. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005;6:21-29.